Navalign LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Navalign LLC's PFE Position: Q1 2026 in Review
Navalign LLC sold out of Pfizer (PFE) in Q1 2026, closing a stake of 6,078 shares — an estimated $151K sold.
Navalign LLC first reported a position in PFE in Q1 2021 and held it in 18 quarters. The position peaked at $1.89M in Q4 2021. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Navalign LLC reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Navalign LLC sold 6,078 Pfizer shares in Q1 2026, an estimated $151K.
- Navalign LLC first reported a position in Pfizer in Q1 2021 and held it in 18 quarters.
- Navalign LLC's Pfizer position peaked at $1.89M in Q4 2021.
- 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Navalign LLC's 13F filing for Q1 2026, filed 29 Apr 2026.